These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 18504283)
1. Follow-up of children exposed antenatally to immunosuppressive drugs. Motta M; Tincani A; Meroni PL; Cimaz R Rheumatology (Oxford); 2008 Jun; 47 Suppl 3():iii32-4. PubMed ID: 18504283 [TBL] [Abstract][Full Text] [Related]
2. Neonates born from mothers with autoimmune disorders. Motta M; Rodriguez-Perez C; Tincani A; Lojacono A; Nacinovich R; Chirico G Early Hum Dev; 2009 Oct; 85(10 Suppl):S67-70. PubMed ID: 19765919 [TBL] [Abstract][Full Text] [Related]
3. [Exposure in utero to immunosuppressives]. Prévot A; Martini S; Guignard JP Rev Med Suisse Romande; 2001 Apr; 121(4):283-91. PubMed ID: 11400400 [TBL] [Abstract][Full Text] [Related]
4. Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants. Biggioggero M; Borghi MO; Gerosa M; Trespidi L; Cimaz R; Meroni PI Lupus; 2007; 16(8):651-6. PubMed ID: 17711903 [TBL] [Abstract][Full Text] [Related]
5. [Fetal drug addiction as a consequence of maternal cocaine free base abuse during pregnancy]. Mena M; Navarrete P; Corvalán S; Bedregal P Rev Med Chil; 2000 Oct; 128(10):1093-100. PubMed ID: 11349507 [TBL] [Abstract][Full Text] [Related]
6. Drugs in pregnancy. Rheumatological disorders. Østensen M Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):953-69. PubMed ID: 11800535 [TBL] [Abstract][Full Text] [Related]
7. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284 [TBL] [Abstract][Full Text] [Related]
8. Prenatal stress and cerebral palsy: a nationwide cohort study in Denmark. Li J; Vestergaard M; Obel C; Precht DH; Christensen J; Lu M; Olsen J Psychosom Med; 2009 Jul; 71(6):615-8. PubMed ID: 19483121 [TBL] [Abstract][Full Text] [Related]
9. Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. Cimaz R; Meregalli E; Biggioggero M; Borghi O; Tincani A; Motta M; Airò P; Meroni PL Toxicol Lett; 2004 Apr; 149(1-3):155-62. PubMed ID: 15093261 [TBL] [Abstract][Full Text] [Related]
10. Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Tincani A; Rebaioli CB; Frassi M; Taglietti M; Gorla R; Cavazzana I; Faden D; Taddei F; Lojacono A; Motta M; Trepidi L; Meroni P; Cimaz R; Ghirardello A; Doria A; Pisoni MP; Muscarà M; Brucato A; Autoimmun Rev; 2005 Sep; 4(7):423-8. PubMed ID: 16137607 [TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drugs in pregnancy: late effects on the children's cognitive abilities. Preliminary data. Perniola T; Buttiglione M; Margari L Acta Neurol (Napoli); 1992; 14(4-6):543-6. PubMed ID: 1293996 [TBL] [Abstract][Full Text] [Related]
12. Cerebral ultrasound abnormalities in infants born to mothers with autoimmune disease. Motta M; Zambelloni C; Rodriguez-Perez C; Angeli A; Lojacono A; Tincani A; Chirico G Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F355-8. PubMed ID: 21242237 [TBL] [Abstract][Full Text] [Related]
13. A study of the teratogenic and fetotoxic effects of large doses of chlordiazepoxide used for self-poisoning by 35 pregnant women. Gidai J; Acs N; Bánhidy F; Czeizel AE Toxicol Ind Health; 2008; 24(1-2):41-51. PubMed ID: 18818180 [TBL] [Abstract][Full Text] [Related]
14. The neurocognitive outcome of IUGR children born to mothers with and without preeclampsia. Leitner Y; Harel S; Geva R; Eshel R; Yaffo A; Many A J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2206-8. PubMed ID: 22524188 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the health status of newborn infants, infants and children from the viewpoint of pre- and perinatal risk factors]. Menzel K Arztl Jugendkd; 1986 Feb; 77(1):1-18. PubMed ID: 3706040 [No Abstract] [Full Text] [Related]
16. In utero exposure to immunosuppressive drugs. Prévot A; Martini S; Guignard JP Biol Neonate; 2002; 81(2):73-81. PubMed ID: 11844873 [TBL] [Abstract][Full Text] [Related]
17. [The role of gestational factors in the formation of irreversible neurologic handicaps]. Doyen J; Thoumsin H; Lambotte R J Gynecol Obstet Biol Reprod (Paris); 1985; 14(4):431-8. PubMed ID: 4031423 [TBL] [Abstract][Full Text] [Related]
18. Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children. Ward MJ; Pauliny J; Lipper EG; Bussel JB Am J Perinatol; 2006 Nov; 23(8):487-92. PubMed ID: 17094038 [TBL] [Abstract][Full Text] [Related]
19. Early weight gain and outcome in Henoch-Schönlein nephritis. Plank C; Vasilache I; Dittrich K; Dötsch J Klin Padiatr; 2010 Dec; 222(7):455-9. PubMed ID: 20862630 [TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience. Loebstein R; Koren G J Psychiatry Neurosci; 1997 May; 22(3):192-6. PubMed ID: 9183118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]